2m 2m 2m 2m 2m 2m 2m
SILO PHARMA (SILO)
NASDAQ
$2.13+$0.03 (+1.48%)
Price as of Sep 11, 2026 7:49 PM EDT- $3.7MMarket Cap
- -78.61%1-Year Change
- BiotechnologyIndustry
SILO PHARMA (SILO)
$2.13+$0.03 (+1.48%)
SILO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.10 | ||
Change | -$0.004 (-0.19%) | ||
Open | $2.19 | ||
High | $2.19 | ||
Low | $2.05 | ||
Previous Close | $2.10 | ||
Volume | 36,762 | ||
30-Day Average Volume | 133,858 | ||
1-Week Change | -12.50% | ||
1-Month Change | -41.01% | ||
1-Year Change | -78.61% | ||
3-Year Change | -92.89% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.8M | ||
Total Assets | $6.0M | ||
Market Cap | $3.7M | ||
Enterprise Value | $404,730.00 | ||
Period: QTR TTM FY | |||
Revenue | $5,818.00 | ||
Net Income | -$834,720.00 | ||
Free Cash Flow | -$781,861.00 | ||
EBIT | -$834,720.00 | ||
EBITDA | -$831,782.00 | ||
Net Working Capital | $4.6M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 70 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/03/2026 | ||
Earnings & Revenue